- The 10-year strategic collaboration builds on strong research
foundations in medical imaging and expands the scope to advance the
delivery of personalized and quality healthcare into 2030 and
beyond.
- Both organizations are members of Wisconsin’s public-private
consortium, led by BioForward, that helped secure the state’s
prestigious Phase 1 Regional Technology and Innovation Hub
designation.
The University of Wisconsin School of Medicine and Public Health
at UW–Madison and GE HealthCare announced today a 10-year strategic
collaboration that builds on an iconic relationship spanning more
than 40 years. The new research collaboration expands the existing
scope beyond medical imaging to new frontiers in digital
technologies and disease-focused solutions.
Combining UW–Madison’s world-class team of physicians,
scientists, and researchers with GE HealthCare’s expertise in
modernizing medical technology, the new collaboration augments
foundations in imaging and medical physics with future plans that
could drive improved diagnosis and disease management through
developments in magnetic resonance (MR), computed tomography (CT),
ultrasound, interventional radiology (IR), Theranostics and
molecular imaging (MI) modalities, as well as patient care
solutions. The collaboration is aimed at shaping the future of
medical imaging, to improve the standard of care and patient
outcomes. Furthermore, it has the potential to advance artificial
intelligence (AI) and digital solutions across the care continuum
to enhance clinical workflows and the delivery of more precise,
personalized care with greater value.
“Our enduring relationship with GE HealthCare has led to
advanced clinical technologies as a result of research that we have
also seamlessly translated from benchtop to bedside and deployed in
real-world clinical settings,” said Thomas Grist, MD, FACR, Chair,
Department of Radiology at UW–Madison. “Technology will continue to
play an important role in providing the best care possible for
patients. With our shared goals of improving experiences for
patients and cultivating more personalized care, the work of our
combined teams has the potential to impact many patients around the
world for years to come.”
Over the past decade, UW-Madison and GE HealthCare have
conducted more than 130 research studies, leading to numerous
scientific and technological advancements. For example, a landmark
study using quantitative MRI to map iron concentration in the liver
showed the potential for early liver disease detection and
management. Additionally, in a study using GE HealthCare’s
TrueFidelity deep learning reconstruction technology for CT
imaging, the research teams optimized CT image quality and
minimized radiation exposure to the patient.
“We have worked with University of Wisconsin–Madison for many
years to help foster the future of biomedical technology, and this
is a natural progression of our collaboration,” said Jay Hill, GE
HealthCare Vice President of Advanced Technologies. “UW–Madison has
a world-class research team ranked among the top ten in the nation
and we are proud to help usher in the next frontier of more
personalized care across key care areas. Our prospective work
together in specialties such as nuclear medicine with emerging
molecular imaging and Theranostics applications could help improve
future patient outcomes for life-threatening diseases such as
prostate cancer.”
The UW–Madison Department of Radiology and Department of Medical
Physics are playing instrumental roles in establishing an Institute
of Theranostics and Particle Therapy within UW Carbone Cancer
Center. With the goal of developing new curative cancer therapies,
the effort demonstrates how research is quickly translating into
patient care.
The decades-long history between GE HealthCare and UW–Madison
has an established track record of combining innovative resources
to transform patient care. Most recently, UW–Madison became the
first U.S. research scanning site for GE HealthCare’s novel
silicon-based photon counting CT prototype [i], engineered with
Deep Silicon detectors with the aim to enhance imaging capabilities
to help clinicians improve patient outcomes. GE HealthCare and
UW-Madison have also partnered to create standardized CT protocols
for GE HealthCare systems that have been distributed to more than
4,000 sites globally. Other areas of past focus include
UW–Madison’s contributions in creating new MR imaging (MRI)
technology, such as GE HealthCare’s SIGNA™ Premier 3T MRI scanner,
as well as GE HealthCare’s AIR™ Recon DL, which utilizes deep
learning algorithms to significantly improve the quality and speed
of MRI scans. More broadly, GE HealthCare has collaborated with
UW-Madison across patient care, monitoring solutions, digital and
AI technology, and medical imaging with initiatives touching key
care pathways in oncology, cardiovascular disease, and
neurology.
GE HealthCare and UW-Madison have built a vital collaborative
research and technology relationship, generating substantial health
innovations including more than 100 patents. Wisconsin recently
received the prestigious Regional Technology and Innovation Hub
(Tech Hub) designation focused on biohealth, selected as one of 31
regions in the country with the highly-competitive Phase 1 Tech Hub
designation.
To learn more about GE HealthCare’s solutions, visit
https://www.gehealthcare.com/.
About University of Wisconsin School of Medicine and Public
Health:
Recognized as an international leader in education, research and
service, the University of Wisconsin School of Medicine and Public
Health continues to evolve to meet changing research, education and
health needs. From creating academic programs targeting health
professional shortage areas to becoming the nation's first school
to integrate medicine and public health, the school consistently
strives to be on the forefront of medical and public health
innovation. The UW School of Medicine and Public Health is made up
of 2,000 faculty members in clinical, basic and applied science
departments, as well as many supporting institutes and centers
across UW–Madison.
About GE HealthCare Technologies Inc.
GE HealthCare is a leading global medical technology,
pharmaceutical diagnostics, and digital solutions innovator,
dedicated to providing integrated solutions, services, and data
analytics to make hospitals more efficient, clinicians more
effective, therapies more precise, and patients healthier and
happier. Serving patients and providers for more than 100 years, GE
HealthCare is advancing personalized, connected, and compassionate
care, while simplifying the patient’s journey across the care
pathway. Together our Imaging, Ultrasound, Patient Care Solutions,
and Pharmaceutical Diagnostics businesses help improve patient care
from diagnosis, to therapy, to monitoring. We are an $18.3 billion
business with 50,000 employees working to create a world where
healthcare has no limits.
Follow us on Facebook, LinkedIn, Twitter, Instagram, and
Insights for the latest news, or visit our website
https://www.gehealthcare.com/ for more information.
[i] Technology in development that represents ongoing research
and development efforts. These technologies are not products and
may never become products. Not for sale. Not cleared or approved by
the U.S. FDA or any other global regulator for commercial
availability. Not CE marked.
GE is a trademark of General Electric Company used under
trademark license. © 2023 GE HealthCare
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231117142457/en/
Sara Pottle Communications – US and Canada GE HealthCare M +1
626 390 7620 sara.pottle@ge.com
GE HealthCare Technologies (NASDAQ:GEHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
GE HealthCare Technologies (NASDAQ:GEHC)
Historical Stock Chart
From Jul 2023 to Jul 2024